Cited by 2,353HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Open access

Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L., Marcotte, T.D., Atkinson, J.H., Rivera-Mindt, M., Vigil, O.R., Taylor, M.J., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T.L., Wong, J., Grant, I., For the CHARTER Group·2010·Neurology

DOI 10.1212/wnl.0b013e318200d727PMC PMC2995535

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatric, and neuropsychological (NP) examinations, and recently published criteria for diagnosing HAND and classifying 3 levels of comorbidity (minimal to severe non-HIV risks for NP impairment). RESULTS: Fifty-two percent of the total sample had NP impairment, with higher rates in groups with greater comorbidity burden (40%, 59%, and 83%). Prevalence estimates for specific HAND diagnoses (excluding severely confounded cases) were 33% for asymptomatic neurocognitive impairment, 12% for mild neurocognitive disorder, and only 2% for HIV-associated dementia (HAD). Among participants with minimal comorbidities (n = 843), history of low nadir CD4 was a strong predictor of impairment, and the lowest impairment rate on CART occurred in the subset with suppressed plasma viral loads and nadir CD4 ≥200 cells/mm(3) (30% vs 47% in remaining subgroups). CONCLUSIONS: The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether early disease events (e.g., profound CD4 decline) may trigger chronic CNS changes, and whether early CART prevents or reverses these changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318200d727

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Beck Depression Inventory–II
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citation
Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
Letendre, S. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 831
Self-citation
The impact of HIV-associated neuropsychological impairment on everyday functioning
Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J. R., Moore, D. J., Bentley, H. A., McCutchan, J. A., REICKS, C., Grant, I., & THE HNRC GROUP (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704102130 · Cited by 726
Self-citation
The HNRC 500-Neuropsychology of Hiv infection at different disease stages
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000230 · Cited by 636
Self-citation
HIV and antiretroviral therapy in the brain: neuronal injury and repair
Ellis, R. J., Langford, D., & Masliah, E. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn2040 · Cited by 533
Self-citation
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
Cartier, L., Hartley, O., Dubois‐Dauphin, M., & Krause, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 520
Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment
Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Comandini, U. V., Vlassi, C., Giulianelli, M., Galgani, S., Antinori, A., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318042e1ee · Cited by 323
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A. E., Heaton, R. K., Wallace, M. R., ABRAMSON, I. S., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 318
Self-citation
Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV
Woods, S. P., Rippeth, J. D., Frol, A. B., Levy, J. K., Ryan, E., Soukup, V. M., Hinkin, C. H., Lazzaretto, D., Cherner, M., Marcotte, T. D., et al. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490509565 · Cited by 311
Self-citation

Show all 33 references

Sorted by citations

Items 301–400 of 1,002

Opportunities for the Development of Neuroimmune Therapies in Addiction
Ray, L. A., Roche, D. J. O., Heinzerling, K. G., & SHOPTAW, S. J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00012-9 · Cited by 60
Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia
Overton, E. T., Kauwe, J. S. K., Paul, R. H., Tashima, K. T., Tate, D. F., Patel, P., Carpenter, C. C. J., Patty, D., Brooks, J. T., & Clifford, D. B. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-0033-9 · Cited by 57
Self-citation
Revised Central Nervous System Neuropenetration-Effectiveness Score is Associated with Cognitive Disorders in HIV-Infected Patients with Controlled Plasma Viraemia
Ciccarelli, N., Fabbiani, M., Colafigli, M., Trecarichi, E. M., Silveri, M. C., Cauda, R., Murri, R., Luca, A. D., & Giambenedetto, S. D. (2013) · Antiviral Therapy · doi:10.3851/imp2560 · Cited by 57
Cognitive Functioning and Driving Simulator Performance in Middle-aged and Older Adults With HIV
Vance, D. E., Fazeli, P. L., Ball, D. A., Slater, L. Z., & Ross, L. A. (2014) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2013.12.001 · Cited by 57
Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders
Fields, J. A., Dumaop, W., Langford, D., Rockenstein, E. M., & Masliah, E. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9520-2 · Cited by 57
HIV ‐1 protein Tat produces biphasic changes in NMDA ‐evoked increases in intracellular Ca2+concentration via activation of Src kinase and nitric oxide signaling pathways
Krogh, K. A., Wydeven, N., Wickman, K. D., & Thayer, S. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12724 · Cited by 57
Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction
Jones, L. D., Jackson, J. W., & Maggirwar, S. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151702 · Cited by 57
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders
Jensen, B. K., Monnerie, H., Mannell, M. V., Gannon, P. J., Akay, C., Erickson, M. A., Bruce‐Keller, A. J., Gelman, B. B., Briand, L. A., Pierce, R. C., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000255 · Cited by 58
Self-citation
Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco
John, M. D. V., Greene, M. L., Hessol, N. A., Zepf, R., Parrott, A. H., Foreman, C., Bourgeois, J. A., Gandhi, M., & Hare, C. B. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001009 · Cited by 61
Productive HIV infection in astrocytes can be established via a nonclassical mechanism
Li, G., Maric, D., Major, E. O., & Nath, A. (2020) · AIDS · doi:10.1097/qad.0000000000002512 · Cited by 58
Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men
Towgood, K. J., Pitkänen, M., Kulasegaram, R., Fradera, A., Soni, S., Sibtain, N. A., Reed, L. J., Bradbeer, C. S., Barker, G. J., Dunn, J., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.22078 · Cited by 56
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
Kanmogne, G. D., Kanmogne, G. D., Singh, S., Roy, U. B., Liu, X., McMillan, Gorantla, Balkundi, Zhou, Y., Alnouti, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29454 · Cited by 56
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease
DeVaughn, S., Müller‐Oehring, E. M., Markey, B. M., Bronte-Stewart, H. M., & Schulte, T. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9305-x · Cited by 56
ApoE ε4 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60
Wendelken, L. A., Jahanshad, N., Rosen, H. J., Busovaca, E., Allen, I. E., Coppola, G., Adams, C., Rankin, K. P., Milanini, B., Clifford, K. M., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001091 · Cited by 57
Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems
Malik, S., & Eugenin, E. A. (2016) · Current HIV Research · doi:10.2174/1570162x14666160324124558 · Cited by 57
Review of functional MRI in HIV: effects of aging and medication
Hakkers, C. S., Arends, J. E., Barth, R. E., du Plessis, S., Hoepelman, A. I. M., & Vink, M. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0483-y · Cited by 56
Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment among HIV-infected Individuals
Keegan, M. R., Chittiprol, S., Letendre, S. L., Winston, A., Fuchs, D., Boasso, A., Iudicello, J. E., & Ellis, R. J. (2016) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s36464 · Cited by 56
Self-citation
Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications
Ojha, C. R., Lapierre, J., Rodriguez, M., Dever, S. M., Zadeh, M. A., DeMarino, C., Pleet, M. L., Kashanchi, F., & El‐Hage, N. (2017) · Viruses · doi:10.3390/v9070176 · Cited by 56
Microorganisms’ Footprint in Neurodegenerative Diseases
Dehhaghi, M., Panahi, H. K. S., & Guillemin, G. J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00466 · Cited by 56
Neurocognitive functioning in acute or early HIV infection
for the CHARTER Group, Moore, D. J., Letendre, S. L., Morris, S., Umlauf, A., Deutsch, R., Smith, D. M., Little, S. J., Rooney, A. S., Franklin, D. R., et al. (2010) · Journal of NeuroVirology · doi:10.1007/s13365-010-0009-y · Cited by 55
Self-citation
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
Nightingale, S., Geretti, A. M., Beloukas, A. I., Fisher, M., Winston, A., Else, L., Nelson, M. R., Taylor, S. R., Ustianowski, A., Ainsworth, J., et al. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0448-1 · Cited by 55
Functional Connectivity in Virally Suppressed Patients with HIV-Associated Neurocognitive Disorder: A Resting-State Analysis
Chaganti, J. R., Heinecke, A., Gates, T. M., Moffat, K., & Brew, B. J. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5246 · Cited by 55
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
Aoki, M., Hayashi, H., Rao, K. V., Das, D., Higashi‐Kuwata, N., Bulut, H., Aoki-Ogata, H., Takamatsu, Y., Yedidi, R. S., Davis, D. A., et al. (2017) · eLife · doi:10.7554/elife.28020 · Cited by 55
CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?
Veenstra, M., Byrd, D., Inglese, M., Buyukturkoglu, K., Williams, D. W., Fleysher, L., Li, M., Gama, L., León‐Rivera, R., Calderon, T. M., et al. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9792-7 · Cited by 55
Self-citation
A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to Reduced Neuroinflammation
Ruiz, A. P., Ajasin, D., Ramasamy, S., DesMarais, V. M., Eugenin, E. A., & Prasad, V. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-39531-5 · Cited by 55
Overview of the structure and function of the dopamine transporter and its protein interactions
Nepal, B., Das, S. K., Reith, M. E. A., & Kortagere, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1150355 · Cited by 54
Deficits in Self-Awareness Impact the Diagnosis of Asymptomatic Neurocognitive Impairment in HIV
Chiao, S., Rosen, H. J., Nicolas, K., Wendelken, L. A., Alcantar, O., Rankin, K. P., Miller, B. L., & Valcour, V. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0229 · Cited by 57
The Relationship of CSF and Plasma Cytokine Levels in HIV Infected Patients with Neurocognitive Impairment
Yuan, L., Liu, A., Qiao, L., Sheng, B., Xu, M. J., Li, W., & Chen, D. (2015) · BioMed Research International · doi:10.1155/2015/506872 · Cited by 54
Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil
de Almeida, S. M., Ribeiro, C. E., Pereira, A. P., Badiee, J., Cherner, M., Smith, D. M., Maich, I., Raboni, S. M., Rotta, I., Barbosa, F. J. L., et al. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0215-5 · Cited by 54
Self-citation
Grit and Ambition are Associated with Better Neurocognitive and Everyday Functioning Among Adults Living with HIV
Moore, R. C., Hussain, M., Watson, C. W.-M., Fazeli, P. L., Marquine, M. J., Yarns, B. C., Jeste, D. V., & Moore, D. J. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2061-1 · Cited by 54
Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system
Hoefer, M. M., Sánchez, A. B., Maung, R., de Rozieres, C. M., Catalan, I. C., Dowling, C. C., Thaney, V. E., Piña-Crespo, J., Zhang, D., Roberts, A. J., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.010 · Cited by 54
CSF Penetration by Antiretroviral Drugs
Eisfeld, C., Reichelt, D., Evers, S., & Husstedt, I. W. (2012) · CNS Drugs · doi:10.1007/s40263-012-0018-x · Cited by 53
The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
Gray, L. R., Tachedjian, G., Ellett, A. M., Roche, M., Cheng, W., Guillemin, G. J., Brew, B. J., Turville, S. G., Wesselingh, S. L., Gorry, P. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062196 · Cited by 53
The Role of HIV Infection in Neurologic Injury
Scutari, R., Alteri, C., Perno, C. F., Svicher, V., & Aquaro, S. (2017) · Brain Sciences · doi:10.3390/brainsci7040038 · Cited by 53
Structural Deep Brain Network Mining
Wang, S., He, L., Cao, B., Lu, C.-T., Yu, P. S., & Ragin, A. B. (2017) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3097983.3097988 · Cited by 53
Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments
Williams, M. E., Zulu, S. S., Stein, D. J., Joska, J. A., & Naudé, P. J. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104701 · Cited by 55
Osteopontin: A key link between immunity, inflammation and the central nervous system
Brown, A. M. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0028-7 · Cited by 52
Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients
Janssen, M. A. M., Bosch, M., Koopmans, P. P., & Kessels, R. P. C. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0324-4 · Cited by 52
HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia
Mishra, R., Chhatbar, C., & Singh, S. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-131 · Cited by 52
Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials
Positive Brain Health Now Investigators, Mayo, N. E., Brouillette, M., & Fellows, L. K. (2016) · BMC Neurology · doi:10.1186/s12883-016-0527-1 · Cited by 52
Untangling the Gordian knot of HIV, stress, and cognitive impairment
Valdez‐Sinon, A. N., Rubin, L. H., & Neigh, G. N. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.02.005 · Cited by 52
Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis
Brouillette, M., Yuen, T., Fellows, L. K., Cysique, L. A., Heaton, R. K., & Mayo, N. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155766 · Cited by 52
Self-citation
White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa
Hoare, J., Fouché, J., Phillips, N. J., Joska, J. A., Paul, R. H., Donald, K. A., Thomas, K. G. F., & Stein, D. J. (2015) · AIDS · doi:10.1097/qad.0000000000000766 · Cited by 52
Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults
Mukerji, S. S., Misra, V., Lorenz, D. R., Cervantes-Arslanian, A. M., Lyons, J. L., Chalkias, S. G., Wurcel, A. G., Burke, D. J., Venna, N., Morgello, S., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001362 · Cited by 52
Self-citation
Efavirenz: what is known about the cellular mechanisms responsible for its adverse effects
Apostolova, N., Blas-Garcia, A., Galindo, M. J., & Esplugues, J. V. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.016 · Cited by 49
A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults
Robbins, R. N., Gouse, H., Brown, H. G., Ehlers, A., Scott, T. M., Leu, C., Remien, R. H., Mellins, C. A., & Joska, J. A. (2018) · JMIR mhealth and uhealth · doi:10.2196/mhealth.9148 · Cited by 52
Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy
Anderson, A. M. L., Easley, K. A., Kasher, N., Franklin, D. R., Heaton, R. K., Zetterberg, H., Blennow, K., Gisslén, M., & Letendre, S. L. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0664-y · Cited by 52
Self-citation
Imaging correlates of the blood–brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications
Chaganti, J. R., Marripudi, K., Staub, L., Rae, C. D., Gates, T. M., Moffat, K., & Brew, B. J. (2019) · AIDS · doi:10.1097/qad.0000000000002300 · Cited by 52
Circulating Levels of ATP Is a Biomarker of HIV Cognitive Impairment
Velasquez, S., Prevedel, L., Valdebenito, S., Górska, A. M., Golovko, M. Y., Khan, N., Geiger, J. D., & Eugenín, E. A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.029 · Cited by 52
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review
Gates, T. M., & Cysique, L. A. (2016) · CNS Drugs · doi:10.1007/s40263-015-0302-7 · Cited by 51
Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study
Milanini, B., Catella, S., Perkovich, B., Esmaeili‐Firidouni, P., Wendelken, L. A., Paul, R. H., Greene, M. L., Ketelle, R., & Valcour, V. (2017) · AIDS Care · doi:10.1080/09540121.2017.1281877 · Cited by 51
Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment
Ulfhammer, G., Edén, A., Mellgren, Å., Fuchs, D., Zetterberg, H., Hagberg, L., Nilsson, S., Yilmaz, A., & Gisslén, M. (2018) · AIDS · doi:10.1097/qad.0000000000001950 · Cited by 51
Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV.
Watson, C. W., Sundermann, E. E., Hussain, M., Umlauf, A., Thames, A. D., Moore, R. C., Letendre, S. L., Jeste, D. V., Morgan, E. E., & Moore, D. J. (2018) · Health Psychology · doi:10.1037/hea0000688 · Cited by 51
Self-citation
HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment
Sanford, R., Strain, J. F., Dadar, M., Maranzano, J., Bonnet, A., Mayo, N. E., Scott, S. C., Fellows, L. K., Ances, B. M., & Collins, D. L. (2019) · AIDS · doi:10.1097/qad.0000000000002193 · Cited by 51
Targeting endoplasmic reticulum stress and autophagy as therapeutic approaches for neurological diseases
Thangaraj, A., Sil, S., Tripathi, A., Chivero, E. T., Periyasamy, P., & Buch, S. J. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2019.11.001 · Cited by 51
Daily Activities Related to Mobile Cognitive Performance in Middle-Aged and Older Adults: An Ecological Momentary Cognitive Assessment Study
Campbell, L. M., Paolillo, E. W., Heaton, A., Tang, B., Depp, C. A., Granholm, E. L., Heaton, R. K., Swendsen, J. D., Moore, D. J., & Moore, R. C. (2020) · JMIR mhealth and uhealth · doi:10.2196/19579 · Cited by 51
Self-citation
Synaptodendritic recovery following HIV Tat exposure: Neurorestoration by phytoestrogens
Bertrand, S. J., Mactutus, C. F., Aksenova, M. V., Espensen-Sturges, T. D., & Booze, R. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12375 · Cited by 51
Nervous system disorders across the life course in resource-limited settings
Birbeck, G. L., Meyer, A.-C. L., & Ogunniyi, A. O. (2015) · Nature · doi:10.1038/nature16031 · Cited by 50
Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy
Kore, I., Ananworanich, J., Valcour, V., Fletcher, J. L. K., Chalermchai, T., Paul, R. H., Reynolds, J., Tipsuk, S., Ubolyam, S., Rattanamanee, S., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000746 · Cited by 50
Risky decision-making in HIV-associated neurocognitive disorders (HAND)
Iudicello, J. E., Woods, S. P., Cattie, J. E., Doyle, K. L., & Grant, I. (2012) · The Clinical Neuropsychologist · doi:10.1080/13854046.2012.740077 · Cited by 50
Self-citation
Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis
Borjabad, A., & Volsky, D. J. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9409-5 · Cited by 51
HIV, aging, and cognition: emerging issues.
Valcour, V. (2013) · Europe PMC (PubMed Central) · Cited by 50
Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection
Foster, S. B., Lu, M., Glaze, D. G., Reuben, J. M., Harris, L. L., Cohen, E. N., Lee, B.-N., Zhao, E., Paul, M. E., Schwarzwald, H., et al. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.04.004 · Cited by 49
Targeted Mitochondrial COQ10 Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells
Velichkovska, M., Surnar, B., Nair, M., Dhar, S., & Toborek, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01014 · Cited by 49
Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV
Watson, C. W., Campbell, L. M., Sun-Suslow, N., Hong, S., Umlauf, A., Ellis, R. J., Iudicello, J. E., Letendre, S. L., Marcotte, T. D., Heaton, R. K., et al. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720001447 · Cited by 49
Self-citation
Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease?
Sheppard, D. P., Woods, S. P., Bondi, M. W., Gilbert, P. E., Massman, P. J., Doyle, K. L., & The HIV Neurobehavioral Research Program (HNRP) Group (2015) · The Clinical Neuropsychologist · doi:10.1080/13854046.2015.1077995 · Cited by 49
Self-citation
Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice
Kesby, J. P., Heaton, R. K., Young, J. W., Umlauf, A., Woods, S. P., Letendre, S. L., Markou, A., Grant, I., & Semenova, S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.39 · Cited by 49
Self-citation
Taming HIV-Related Inflammation with Physical Activity: A Matter of Timing
d’Ettorre, G., Ceccarelli, G., Giustini, N., Mastroianni, C. M., Silvestri, G., & Vullo, V. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0069 · Cited by 49
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
Kamal, S., Locatelli, I., Wandeler, G., Sehhat, A., Bugnon, O., Métral, M., Pasquier, R. D., Gutbrod, K., Cavassini, M. L., Schneider, M. P., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx070 · Cited by 49
The role of catecholamines in HIV neuropathogenesis
Nolan, R. A., & Gaskill, P. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.030 · Cited by 50
Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome
Tso, F. Y., Kang, G., Kwon, E. H., Julius, P., Li, Q., West, J. T., & Wood, C. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201325 · Cited by 49
Impact of urbanization on cognitive disorders
Robbins, R. N., Scott, T. M., Joska, J. A., & Gouse, H. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000490 · Cited by 51
Different roles of frontal versus striatal atrophy in HIV‐associated neurocognitive disorders
Israel, S. M., Hassanzadeh‐Behbahani, S., Turkeltaub, P. E., Moore, D. J., Ellis, R. J., & Jiang, X. (2019) · Human Brain Mapping · doi:10.1002/hbm.24577 · Cited by 51
Self-citation
Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study
Alford, K. A., Daley, S., Banerjee, S., & Vera, J. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251944 · Cited by 49
Identification of Novel T Cell Factor 4 (TCF-4) Binding Sites on the HIV Long Terminal Repeat Which Associate with TCF-4, β-Catenin, and SMAR1 To Repress HIV Transcription
Henderson, L. J., Narasipura, S. D., Adarichev, V. A., Kashanchi, F., & Al‐Harthi, L. (2012) · Journal of Virology · doi:10.1128/jvi.00486-12 · Cited by 49
Cognitive Intra-individual Variability in HIV: an Integrative Review
Vance, D. E., Bene, V. A. D., Sandson, J., Billings, R., Triebel, K. L., Buchholz, A. S., Rubin, L. H., Woods, S. P., Li, W., & Fazeli, P. L. (2021) · Neuropsychology Review · doi:10.1007/s11065-021-09528-x · Cited by 48
Self-citation
HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research
Churchill, M. J., Cowley, D., Wesselingh, S. L., Gorry, P. R., & Gray, L. R. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0271-5 · Cited by 48
Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States
Meade, C. S., Towe, S. L., Skalski, L. M., & Robertson, K. R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.034 · Cited by 48
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
Torti, C., Focà, E., Cesana, B. M., & Lescure, F. X. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-138 · Cited by 48
Cancer and the ‘other’ noncommunicable chronic diseases in older people living with HIV/AIDS in resource-limited settings
Hirschhorn, L. R., Kaaya, S., Garrity, P. S., Chopyak, E., & Fawzi, M. C. S. (2012) · AIDS · doi:10.1097/qad.0b013e328355ab72 · Cited by 48
Aging and HIV/AIDS: Neurocognitive Implications for Older HIV-Positive Latina/o Adults
Mindt, M. R., Miranda, C., Arentoft, A., Byrd, D., Monzones, J., Fuentes, A., Arias, F., Rentería, M. A., Rosario, A. K., & Morgello, S. (2014) · Behavioral Medicine · doi:10.1080/08964289.2014.914464 · Cited by 48
Self-citation
Prevalence of HIV associated neurocognitive deficit among HIV positive people in Ethiopia: a cross sectional study at Ayder Referral Hospital
Mossie, T. B., Takelle, G. M., & Yemiyamrew, E. (2017) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v27i1.9 · Cited by 48
Positive Psychological Factors are Linked to Successful Cognitive Aging Among Older Persons Living with HIV/AIDS
Moore, D. J., Fazeli, P. L., Moore, R. C., Woods, S. P., Letendre, S. L., Jeste, D. V., & Grant, I. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-2001-5 · Cited by 49
Self-citation
A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates
Kim, S., Hahn, Y. K., Podhaizer, E. M., McLane, V. D., Zou, S., Hauser, K. F., & Knapp, P. E. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1320-4 · Cited by 48
The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease
Rubin, L. H., Sundermann, E. E., & Moore, D. J. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0702-9 · Cited by 53
Association of HIV infection and cognitive impairment in older adults: A meta-analysis
Deng, L., Zhang, X., Gao, Y., Turner, D. E., Qian, F., Lu, H. J., Vermund, S. H., Zhang, Y., & Qian, H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101310 · Cited by 47
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program
Riggs, P. K., Chaillon, A., Jiang, G., Letendre, S. L., Tang, Y., Taylor, J., Kaytes, A., Smith, D. M., Dubé, K., & Gianella, S. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00628-8 · Cited by 47
Self-citation
Time and Time Again: Temporal Processing Demands Implicate Perceptual and Gating Deficits in the HIV-1 Transgenic Rat
Moran, L. M., Booze, R. M., & Mactutus, C. F. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9472-6 · Cited by 47
HIV-1 Effects on Neuropsychological Performance in a Resource-Limited Country, Zambia
Holguin, A., Banda, M., Willen, E. J., Malama, C., Chiyeñu, K. O. R., Mudenda, V. C., & Wood, C. A. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9988-9 · Cited by 47
Relationships Among Neurocognitive Status, Medication Adherence Measured by Pharmacy Refill Records, and Virologic Suppression in HIV-Infected Persons
Andrade, A. S., Deutsch, R., Celano, S. A., Duarte, N. A., Marcotte, T. D., Umlauf, A., Atkinson, J. H., McCutchan, J. A., Franklin, D. R., Alexander, T. J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31827ed678 · Cited by 47
Self-citation
A better screening tool for HIV-associated neurocognitive disorders
Brouillette, M.-J., Mayo, N. E., Fellows, L. K., Lebedeva, E., Higgins, J., Overton, E. T., Ances, B. M., & Koski, L. M. (2013) · AIDS · doi:10.1097/qad.0000000000000152 · Cited by 47
Major Depressive Disorder, Cognitive Symptoms, and Neuropsychological Performance among Ethnically Diverse HIV+ Men and Women
Fellows, R. P., Byrd, D., & Morgello, S. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712001245 · Cited by 47
Self-citation
Molecular Mechanism of HIV-1 Tat Interacting with Human Dopamine Transporter
Yuan, Y., Huang, X., Midde, N. M., Quizon, P. M., Sun, W., Zhu, J., & Zhan, C. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00001 · Cited by 47
Changes in cognitive function in women with HIV infection and early life stress
Spies, G., Fennema‐Notestine, C., Cherner, M., & Seedat, S. (2016) · AIDS Care · doi:10.1080/09540121.2016.1204417 · Cited by 47
Self-citation
A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults
Dufour, C. A., Marquine, M. J., Fazeli, P. L., Umlauf, A., Henry, B. L., Zlatar, Z. Z., Montoya, J. L., Ellis, R. J., Grant, I., & Moore, D. J. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1643-z · Cited by 49
Self-citation
Impact of Alcohol on HIV Disease Pathogenesis, Comorbidities and Aging: Integrating Preclinical and Clinical Findings
Molina, P. E., Simon, L., Amedee, A. M., Welsh, D. A., & Ferguson, T. F. (2018) · Alcohol and Alcoholism · doi:10.1093/alcalc/agy016 · Cited by 48
Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment
Underwood, J., Francesco, D. D., Leech, R., Sabin, C. A., & Winston, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194760 · Cited by 47
Purinergic signaling in infectious diseases of the central nervous system
Alves, V. S., Leite-Aguiar, R., da Silva, J. P., Coutinho‐Silva, R., & Savio, L. E. B. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.026 · Cited by 49
HIV-related neurocognitive disorders: Diagnosis, Treatment, and Mental Health Implications: A Review
Elendu, C., Aguocha, C., Okeke, C. V., Okoro, C. B., & Peterson, J. C. (2023) · Medicine · doi:10.1097/md.0000000000035652 · Cited by 46
Functional disability in medication management and driving among individuals with HIV: A 1-year follow-up study
Thames, A. D., Arentoft, A., Mindt, M. R., & Hinkin, C. H. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2012.747596 · Cited by 46

Authors: Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T. L., Wong, J., Grant, I., & For the CHARTER Group
Affiliations: University of California San Diego (US)
From the University of California (R.K.H., D.R.F., S.P.W., C.A., F.V., R.J.E., S.L.L., T.D.M., J.H.A., O.R.V., M.J.T., J.A.M., I.A., A.G., C.F.-N., T.L.J., I.G.), San Diego; University of California (J.W.), San Francisco; Washington University (D.B.C.), St. Louis, MO; Mount Sinai School of Medicine (M.R.-M., S.M., D.M.S.), New York, NY; University of Washington (A.C.C., C.M.M.), Seattle; University of Texas Medical Branch (B.B.G.), Galveston; and Johns Hopkins University (J.C.M.), Baltimore, MD.
ORCID: Heaton, R.K.
Clifford, D.B.
Franklin, D.R.
Woods, S.P.
Vaida, F.
Ellis, R.J.
Letendre, S.L.
Marcotte, T.D.
Taylor, M.J.
Collier, A.C.
Marra, C.M.
McArthur, J.C.
Morgello, S.
Simpson, D.M.
McCutchan, J.A.
Jernigan, T.L.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-12-07
Volume: 75
Issue: 23
Pages: 2087-2096
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0b013e318200d727
PMC: PMC2995535
OpenAlex: W2137321682
Cited by: 2,353
References: 33
Citations by year: 2026: 92 · 2025: 93 · 2024: 119 · 2023: 131 · 2022: 127 · 2021: 182 · 2020: 172 · 2019: 225 · 2018: 153 · 2017: 202 · 2016: 181 · 2015: 172 · 2014: 165 · 2013: 152 · 2012: 115
FWCI: 38.09
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Neurology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Fordham Research Commons (Fordham University) (submittedVersion)
Funders: National Institutes of Health (5u01ai069495-05, n01mh22005-16-0-1, 5r01ag024506-03, 5r01ns036524-10, N01 MH22005, MH22005)
Centers for Disease Control and Prevention (U2G PS00623)
U.S. Public Health Service (R213857-53187, NIMH-22005)
National Institute on Alcohol Abuse and Alcoholism (R01 AA13419, R01AA013419, R32AA17321)
National Institute on Aging (R01AG015301, U01‐AG10483, R01AG031224, R01-AG024506, R01 AG-15301, U01AG010483, R01AG022381, U19AG010483)
National Heart, Lung, and Blood Institute (R01HL084229, R01 HL95089, R01 HL84229, R01HL095089)
National Institute of Mental Health (U01MH083507, U01-MH83506, R21-MH85610, R01MH067831, U01MH083506, R01-MH73419, N01 MH-22005, R01 MH73433, R01MH079881, N01 MH22005-08, R01 MH-60720, R01 MH78748, R01MH058076, R21MH78728, MH 22005, N01MH022005, R01MH064907, K23MH079718, R01MH081861, MH058076, R01MH085608, R01 MH78737, R01MH64907, R01MH083552, R01MH073419, R24-MH-59724, U13 MH81676, R32 MH77487, R01MH079886, R24MH059724, R21MH078728, U01MH083501, R01MH38552, R01MH078737, R21MH085610, R01 MH81861, R01 MH83552, R01 MH79752, R01MH078748, R01MH073433, R01MH079752, R01MH060720, P30MH62512, R01MH061146, MH085608-01, MH083506-02, R01 MH61146, R01 MH79881, R01 MH075673, R21MH083573, R01MH084796, MH083552-02, P30MH062512, U13MH081676, R01 MH58076)
National Institute on Drug Abuse (P50DA026306, R01 DA21115, RC2DA029475, DA026306-01, P01DA012065, P50DA26306, RC2-DA29475, P01-DA12065, DA012065-10, DA026146, P01DA026146, R03DA022137, R01DA021115)
National Institute of Allergy and Infectious Diseases (AI 27757, R01-AI47033, AI-069434, AI069918, UO1AI69495, U01 AI74521, U01AI074521, R01AI034235, U01AI069432, R01AI047033, 00-AI-0005, U01 AI69432, R01AI087145, P01AI057005, AI069438, AI068543, 1R01 NS/AI34235, P30AI027757, U01AI069918)
National Institute of Neurological Disorders and Stroke (R01 NS44807, R21NS069355, R01NS049465, UO1 NS32228, R01NS044807, R01NS49465, RC1NS068904, R01-NS-41198, R01NS041198, R01-NS36524, R01NS051132, U01NS032228)
National Center for Research Resources (U24RR021992, U24RR021382, K30RR22681, K30RR022681, U24 RR21382, U24RR019701)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: HIV-associated neurocognitive disorders, HIV-associated dementia, highly active antiretroviral therapy, CD4 nadir, viral suppression, comorbidities, asymptomatic neurocognitive impairment, mild neurocognitive disorder, HIV infection
MeSH terms: Activities of Daily Living, Adult, Algorithms, Cognition Disorders, Disability Evaluation, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Neurologic Examination, Neuropsychological Tests, Psychiatric Status Rating Scales, Retrospective Studies, Models, Statistical, HIV Infections, Cross-Over Studies, Observation, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks